期刊文献+

CIA小鼠血清中IL-27、IL-10、IL-17的动态分析 被引量:12

Dynamic changes of IL-27,IL-10,IL-17 in serum of collagen-induced arthritis in mice
下载PDF
导出
摘要 目的:观察鸡Ⅱ型胶原诱导型关节炎(CIA)小鼠血清中IL-27、IL-17、IL-10的动态变化。方法:54只DBA1/J小鼠随机分为对照组(每组6只)和模型组(每组12只),分别在CIA小鼠病程进展的早、中、晚期无菌摘眼球取血,常规分离血清,应用流式细胞术检测各组小鼠在疾病病程的早、中、晚期血清中细胞因子IL-27、IL-17、IL-10的动态变化情况。结果:模型组IL-27在疾病早期、中期显著下降(P<0.05;P<0.01),疾病晚期与对照组比较差异无统计学意义(P>0.05);模型组IL-17在疾病的早期及晚期与对照组比较无明显区别(P>0.05),而在病程中期显著高于对照组(P<0.05)。IL-10在CIA小鼠的病程进展中,模型组与对照组相比差异无明显区别(P>0.05)。结论:细胞因子IL-27和IL-17、IL-10可能参与CIA发病,可能与胶原诱导型关节炎的炎症进展有一定关系。 Objective: To observe chicken type Ⅱ collagen-induced arthritis( CIA) in serum of mice with the dynamic changes of IL-27,IL-17,IL-10. Methods: 54 DBA1 / J mice were randomly divided into control group( n = 6) and model group( n = 12),according to the progress of CIA mouse course early,middle and late( 7,14,and 35 days after booster immunization),taking the eyeball for blood and separating the serum under sterile condition. The dynamic levels of cytokines IL-27,IL-17,IL-10 were detected by flow cytometry. Results: The level of IL-27 in the model group was significantly declined in the the progress of CIA mouse course early and middle( P〈0. 05,P〈0. 01) compared with the control group,but there was no significant difference between late disease and control group( P〉0. 05); the level of IL-17 in the disease early and late was no significant difference( P〉0. 05) compared with the control group,while in the mid course significantly higher than control group( P〈0. 05) during the course of disease. The level of IL-10 showed no difference from the experiment beginning( P〉0. 05). Conclusion: IL-27,IL-17,IL-10 paticipate in the pathogenesis of CIA and their alterations at different stages of the disease have a relation to the development of arthritis.
机构地区 承德医学院
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2015年第6期803-805,821,共4页 Chinese Journal of Immunology
基金 国家自然科学基金(81273986)资助
关键词 胶原诱导型关节炎 IL-17 IL-27 IL-10 流式细胞术 Collagen-induced arthritis IL-17 IL-27 IL-10 Flow cytometry
  • 相关文献

参考文献14

  • 1Yudoh K, Matsuno H. Reduce expression of regulatory CD4+ cell subset is relhted to Thl/Th2 balance and diseas severity in rheumatoid arthritis[ J]. Arthritis Rheum ,2000,43:617-627.
  • 2徐雪,吕玲.白细胞介素-17与类风湿关节炎[J].中华风湿病学杂志,2008,12(10):719-721. 被引量:14
  • 3Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance[ J ]. Ce11,2008,133 ( 5 ) :775.
  • 4Pflanz S, Hibbert L, Mattson J, et al. WSX-1 and glycoprotein 130 constitute a signal transducing receptor for IL-27 [ J ]. J Immunol, 2004,172(4) :2225-2231.
  • 5郭明,封桂英,郭亚春,宋鸿儒,邢恩鸿,潘福栋,安高.Th1型细胞因子在胶原蛋白诱导性关节炎小鼠血清中的动态变化[J].细胞与分子免疫学杂志,2014,30(3):250-253. 被引量:15
  • 6Welles WL, Batlisto JR. Suppression of adjuvant arthritis by antibodies specific for collagen type II [ J ]. Immunol Commun, 1981,10(8) :673-685.
  • 7Hueber W. Effects of AIN457, a fully human antibody to interleukin-17 A, on psoriasis, rheumatoid arthritis, and uveitis [ J ]. Sci Translation Med,2010,2(52) :52-72.
  • 8井申荣,邹全明.白细胞介素10的研究进展[J].免疫学杂志,2006,22(z1):26-28. 被引量:16
  • 9Carter NA, Rosser EC, Maufi C. Interleukin-10 produced by B cells is crucial for the suppression of Thl7/Thl responses, induction of T regulatory type I cells and reduction of collagen -induced arthritis [ J ]. Arthritis Res Ther,2012,14 ( 1 ) : R32.
  • 10Yang M, Deng J, Liu Y, et al. IL-10-preducing regulatory B10 cells ameliorate collagen -induced arthritis via suppressing Thl7 cell generation [J]. Am J Pathol,2012,180(6) :2375-2385.

二级参考文献73

  • 1姜波,吴红,陈世锋,吴隆敬.可溶性细胞间黏附分子-1和可溶性选择素E在自身免疫性风湿病中的表达[J].中华风湿病学杂志,2006,10(4):230-232. 被引量:5
  • 2Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol, 2002, 71: 1-8.
  • 3Starnes T, Broxmeyer HE, Robertson M J, et al. Cutting edge: IL- 17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol, 2002, 169: 642- 646.
  • 4Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med, 2007, 13: 139-145.
  • 5Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther, 2005, 7: 29-37.
  • 6Ivaylo Il, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentialion program of proinflammalory IL-17^+ T helper cells. Cell, 2006, 126:1121-1133.
  • 7Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest, 2006. 116: 1218-1222.
  • 8Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol, 2006, 18: 349-356.
  • 9Miranda-Carus ME, Balsa A, Benito-Miguel M, et al. IL-15 and initiation of cell eontant-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis:effect of methotrexate. J Immunol, 2004, 173: 1463-1476.
  • 10Stamp LK, Cleland LG, James MJ. Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and necrosis factor-alpha..J Rheumatol, 2004, 31: 1246-1254.

共引文献66

同被引文献93

引证文献12

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部